Sanofi
Sanofi is a global healthcare company operating in over 90 countries, employing more than 91,000 people, and focusing on immunology, neurology, oncology, rare blood disorders, rare diseases, and vaccines. The company is committed to environmental sustainability, diversity, equity, and inclusion, and utilizes advanced technology platforms such as mRNA and artificial intelligence in its research and development efforts.
Sanofi Global Operations
Sanofi operates in over 90 countries, employing more than 91,000 people globally. The company maintains a significant presence worldwide, ensuring its healthcare solutions reach diverse populations. Sanofi's extensive operations support its wide range of consumer healthcare products and various therapeutic areas. Listed on both the Euronext Paris and Nasdaq Global Select Market, Sanofi has firmly established itself as a global leader in the pharmaceutical industry.
Research and Development at Sanofi
Sanofi has a robust R&D pipeline with 77 clinical-stage projects, including 30 that are in phase 3 or submitted for regulatory approval. The company focuses on six therapeutic areas: Immunology and Inflammation, Oncology, Rare Diseases, Rare Blood Disorders, Neurology, and Vaccines. Sanofi utilizes a variety of technology platforms, such as mRNA, artificial intelligence, SYNTHORIN™ molecules, and NANOBODY® molecules, to drive innovation and advance its research efforts.
Sanofi's Focus on Vaccines
Sanofi is the global leader in the production of poliomyelitis and influenza vaccines. The company develops vaccines that protect over 500 million people annually and produces 2.5 million vaccine doses each day. Sanofi's vaccine portfolio includes inactivated vaccines, live-attenuated vaccines, polysaccharide-based vaccines, recombinant protein vaccines, and conjugated-polysaccharide vaccines. Additionally, Sanofi is constructing two new EVolutive Facilities in France and Singapore to enhance its vaccine production capabilities.
Sanofi's Commitment to Sustainability and Diversity
Sanofi is committed to environmental sustainability and aims to achieve net zero emissions by 2045. The company operates state-of-the-art manufacturing sites that leverage big data and digital technologies. Additionally, Sanofi's EVolutive Facilities are designed to be nearly carbon-neutral, utilizing green electricity and solar panels. Sanofi is also dedicated to diversity, equity, and inclusion, both within the workplace and in broader society, including its clinical trials and patient support programs.
Sanofi's Consumer Healthcare Products
Sanofi offers a range of consumer healthcare products catering to various health needs. These include products for allergy relief, cough, cold & flu, digestive wellness, pain care, and physical & mental wellness. Sanofi's consumer healthcare segment ensures that patients and consumers have access to effective and reliable health solutions for their everyday needs.